Cargando…

High content screening for drug discovery from traditional Chinese medicine

Traditional Chinese medicine (TCM) represents the crystallization of Chinese wisdom and civilization. It has been valued as the renewable source for the discovery of novel drugs, owing to its long-term proved efficacy in human diseases and abundant biologically active components pools. To dissect th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Wu, Ming-Yue, Tan, Jie-Qiong, Li, Min, Lu, Jia-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394041/
https://www.ncbi.nlm.nih.gov/pubmed/30858873
http://dx.doi.org/10.1186/s13020-019-0228-y
_version_ 1783398811963490304
author Wang, Jing
Wu, Ming-Yue
Tan, Jie-Qiong
Li, Min
Lu, Jia-Hong
author_facet Wang, Jing
Wu, Ming-Yue
Tan, Jie-Qiong
Li, Min
Lu, Jia-Hong
author_sort Wang, Jing
collection PubMed
description Traditional Chinese medicine (TCM) represents the crystallization of Chinese wisdom and civilization. It has been valued as the renewable source for the discovery of novel drugs, owing to its long-term proved efficacy in human diseases and abundant biologically active components pools. To dissect the mystery of TCM, modern technologies such as omics approaches (proteomics, genomics, metabolomics) and drug screening technologies (high through-put screening, high content screening and virtual screening) have been widely applied to either identify the drug target of TCM or identify the active component with certain bio-activity. The advent of high content screening technology has absolutely contributed to a breakthrough in compounds discovery and influenced the evolution of technology in screening field. The review introduces the concept and principle of high content screening, lists and compares the currently used HCS instruments, and summarizes the examples from ours and others research work which applied HCS in TCM-derived compounds screening. Meanwhile, this article also discusses the advantages and limitations of HSC technology in drug discovery from TCM libraries.
format Online
Article
Text
id pubmed-6394041
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63940412019-03-11 High content screening for drug discovery from traditional Chinese medicine Wang, Jing Wu, Ming-Yue Tan, Jie-Qiong Li, Min Lu, Jia-Hong Chin Med Review Traditional Chinese medicine (TCM) represents the crystallization of Chinese wisdom and civilization. It has been valued as the renewable source for the discovery of novel drugs, owing to its long-term proved efficacy in human diseases and abundant biologically active components pools. To dissect the mystery of TCM, modern technologies such as omics approaches (proteomics, genomics, metabolomics) and drug screening technologies (high through-put screening, high content screening and virtual screening) have been widely applied to either identify the drug target of TCM or identify the active component with certain bio-activity. The advent of high content screening technology has absolutely contributed to a breakthrough in compounds discovery and influenced the evolution of technology in screening field. The review introduces the concept and principle of high content screening, lists and compares the currently used HCS instruments, and summarizes the examples from ours and others research work which applied HCS in TCM-derived compounds screening. Meanwhile, this article also discusses the advantages and limitations of HSC technology in drug discovery from TCM libraries. BioMed Central 2019-02-28 /pmc/articles/PMC6394041/ /pubmed/30858873 http://dx.doi.org/10.1186/s13020-019-0228-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Wang, Jing
Wu, Ming-Yue
Tan, Jie-Qiong
Li, Min
Lu, Jia-Hong
High content screening for drug discovery from traditional Chinese medicine
title High content screening for drug discovery from traditional Chinese medicine
title_full High content screening for drug discovery from traditional Chinese medicine
title_fullStr High content screening for drug discovery from traditional Chinese medicine
title_full_unstemmed High content screening for drug discovery from traditional Chinese medicine
title_short High content screening for drug discovery from traditional Chinese medicine
title_sort high content screening for drug discovery from traditional chinese medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394041/
https://www.ncbi.nlm.nih.gov/pubmed/30858873
http://dx.doi.org/10.1186/s13020-019-0228-y
work_keys_str_mv AT wangjing highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine
AT wumingyue highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine
AT tanjieqiong highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine
AT limin highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine
AT lujiahong highcontentscreeningfordrugdiscoveryfromtraditionalchinesemedicine